Morphocell Technologies

Morphocell Technologies is a Montreal-based regenerative medicine company dedicated to developing stem cell-derived tissue and organ replacement therapies. Its proprietary iPSC-derived platform supports a range of tissue engineering solutions for severe organ dysfunction, with liver disease as its primary focus. Founded in 2018, Morphocell combines scientific excellence, clinical expertise, and cutting-edge manufacturing technologies to bring next-generation regenerative therapies to patients worldwide.